Technology | 2019.10.30
Veran Medical Technologies announces first patient enrolled in multi-center study evaluating a new method of identifying pulmonary nodules during lung cancer surgeries.
Veran’s FDA approved SPiN Thoracic Navigation System™ is being utilized to percutaneously localize lung nodules with high likelihood of lung cancer. The intraoperative localization helps Thoracic Surgeons identify these nodules during surgical resection to enable a minimally-invasive approach.
(PRWeb October 30, 2019)
For more information, please visit
https://www.prweb.com/releases/veran_med[...]er_surgeries/prweb16684169.htm
